Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Chemocentryx Inc. (CCXI)
NASDAQ:CCXI
Holding CCXI?
Track your performance easily
See the Price Targets and Ratings of:
CCXI Analyst Ratings
Hold
0 Buy
8 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
CCXI Stock 12 Month Forecast
Average Price Target
$52.00
▲(0.02% Upside)
| Highest Price Target$52.00 | Average Price Target$52.00 | Lowest Price Target$52.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Stifel Nicolaus
$52
Hold
0.02%
Upside
Downgraded
08/10/22
Benzingas Top Ratings Upgrades, Downgrades For August 10, 2022For ChemoCentryx Inc CCXI , Stifel downgraded the previous rating of Buy to Hold. In the second quarter, ChemoCentryx showed an EPS of $0.44, compared to $0.56 from the year-ago quarter. At the moment, the stock has a 52-week-high of $50.94 and a 52-week-low of $14.95. ChemoCentryx closed at $50.79 at the end of the last trading period.
H.C. Wainwright
$52
Hold
0.02%
Upside
Reiterated
08/09/22
Analysts Offer Insights on Healthcare Companies: ChemoCentryx (NASDAQ: CCXI) and ATI Physical Therapy (NYSE: ATIP)
J.P. Morgan
$52
Hold
0.02%
Upside
Reiterated
08/08/22
Analysts' Opinions Are Mixed on These Healthcare Stocks: BioCryst (NASDAQ: BCRX), ChemoCentryx (NASDAQ: CCXI) and Heska (NASDAQ: HSKA)
Canaccord Genuity
$52
Hold
0.02%
Upside
Downgraded
08/05/22
Canaccord Genuity downgrades ChemoCentryx (CCXI) to HoldCanaccord Genuity analyst Ed Nash downgraded ChemoCentryx (NASDAQ: CCXI) from Buy to Hold with a price target of $52.00.
SVB Securities
$52
Hold
0.02%
Upside
Downgraded
08/05/22
SVB Leerink Downgrades ChemoCentryx to Market Perform, Lowers Price Target to $52
Piper Sandler
$52
Hold
0.02%
Upside
Downgraded
08/04/22
ChemoCentryx (CCXI) downgraded to Neutral from Overweight at Piper SandlerPiper Sandler analyst Edward Tenthoff downgraded ChemoCentryx to Neutral from Overweight with a $52 price target after Amgen (AMGN) announced its intention to acquire the company for $4B or $52.00 per share in cash. The analyst cites the pending takeover for the downgrade.
Raymond James
―
Hold
―
Downgraded
08/04/22
Raymond James Downgrades ChemoCentryx to Market Perform
Unknown Analyst
Not Ranked
Wells Fargo
$52
Hold
0.02%
Upside
Downgraded
08/04/22
Wells Fargo downgrades ChemoCentryx (CCXI) to Equal WeightWells Fargo downgraded ChemoCentryx (NASDAQ: CCXI) from Overweight to Equal Weight with a price target of $52.00.
CCXI Analyst Recommendation Trends
Currently, no data available
Please return soon. This page is being updated.
Each month's total comprises the sum of three months' worth of ratings.
CCXI Financial Forecast
CCXI Stock Forecast FAQ
What is CCXI’s average 12-month price target, according to analysts?
Based on analyst ratings, Chemocentryx Inc.’s 12-month average price target is $52.00.
What is CCXI’s upside potential, based on the analysts’ average price target?
Chemocentryx Inc. has 0.02% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is CCXI a Buy, Sell or Hold?
Chemocentryx Inc. has a consensus rating of Hold which is based on 0 buy ratings, 8 hold ratings and 0 sell ratings.
What is Chemocentryx Inc.’s price target?
The average price target for Chemocentryx Inc. is $52.00. This is based on 8 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $52.00 ,the lowest forecast is $52.00. The average price target represents 0.02% Increase from the current price of $51.99.
The highest analyst price target is $52.00 ,the lowest forecast is $52.00. The average price target represents 0.02% Increase from the current price of $51.99.
What do analysts say about Chemocentryx Inc.?
Chemocentryx Inc.’s analyst rating consensus is a Hold. This is based on the ratings of 8 Wall Streets Analysts.
How can I buy shares of CCXI?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.